Publication:
CD161 Defines a Functionally Distinct Subset of Pro-Inflammatory Natural Killer Cells

Thumbnail Image

Open/View Files

Date

2018

Published Version

Journal Title

Journal ISSN

Volume Title

Publisher

Frontiers Media S.A.
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Kurioka, A., C. Cosgrove, Y. Simoni, B. van Wilgenburg, A. Geremia, S. Björkander, E. Sverremark-Ekström, et al. 2018. “CD161 Defines a Functionally Distinct Subset of Pro-Inflammatory Natural Killer Cells.” Frontiers in Immunology 9 (1): 486. doi:10.3389/fimmu.2018.00486. http://dx.doi.org/10.3389/fimmu.2018.00486.

Research Data

Abstract

CD161 is a C-type lectin-like receptor expressed on the majority of natural killer (NK) cells; however, the significance of CD161 expression on NK cells has not been comprehensively investigated. Recently, we found that CD161 expression identifies a transcriptional and innate functional phenotype that is shared across various T cell populations. Using mass cytometry and microarray experiments, we demonstrate that this functional phenotype extends to NK cells. CD161 marks NK cells that have retained the ability to respond to innate cytokines during their differentiation, and is lost upon cytomegalovirus-induced maturation in both healthy and human immunodeficiency virus (HIV)-infected patients. These pro-inflammatory NK cells are present in the inflamed lamina propria where they are enriched for integrin CD103 expression. Thus, CD161 expression identifies NK cells that may contribute to inflammatory disease pathogenesis and correlates with an innate responsiveness to cytokines in both T and NK cells.

Description

Keywords

natural killer cells, CD161, pro-inflammatory cytokines, cytomegalovirus, human immunodeficiency virus, inflammatory bowel diseases

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Referenced By

Related Stories